NSE · NECLIFE
Nectar Lifesciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,427
of 5,004 stocks
▼ 21W
Peak #2,425 · 21 Sep 2026
Nectar Lifesciences Limited, a microcap Healthcare business, is seeing revenue contract sharply, has a subdued return on equity, and has promoters holding 52%.
Market Cap
203.97 Cr
P/E Ratio
—
P/B Ratio
0.35
ROE
-50.30%
ROCE
-8.69%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 1.45 L | Rs 0 | Rs 0 | 5.00 Cr |
| Net Profit | -15.40 Cr | -67.92 Cr | 14.27 Cr | -176.01 Cr |
| EPS | -0.79 | -3.38 | 0.64 | -7.84 |
| Operating Profit | -24.46 Cr | -51.03 Cr | -1.33 Cr | -50.62 L |
Shareholding pattern
Promoter
51.84%
Public
48.16%
Mutual fund holdings
₹0.00
Cr total
2
Schemes
2
Fund Houses
₹0.00 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.00 Cr (64.3%)
Bandhan Mutual Fund₹0.00 Cr (35.7%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Dec 2025 | Buyback | Buy Back |
| 13 Sep 2024 | Other | Annual General Meeting |
| 14 Sep 2023 | Other | Annual General Meeting |
| 13 Sep 2022 | Other | Annual General Meeting |
| 13 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.